Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | investor protection violation | 2003 | SEC | $1,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | drug or medical equipment safety violation | 2002 | DOJ_CIVIL | $500,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $55,000,000 |
Schering-Plough Healthcare Products Inc. | Merck | pharmaceuticals | pesticide violation | 2011 | CA-DPR | $28,400 |
SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. ( SB) | Merck | pharmaceuticals | environmental violation | 2007 | EPA | $40,950 |
SCHERING-PLOUGH PRODUCTS LLC | Merck | pharmaceuticals | hazardous waste violation | 2001 | EPA | $54,100 |
Schering-Plough Products, LLC | Merck | pharmaceuticals | air pollution violation | 2011 | EPA | $260,000 |
SCHWARZ PHARMA MANUFACTURING, INC. | UCB | pharmaceuticals | workplace safety or health violation | 2010 | OSHA | $6,750 |
Scios Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
Seagen Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $29,974 |
SEARLE LTD | Pfizer | pharmaceuticals | hazardous waste violation | 2002 | EPA | $95,000 |
Shering-Plough/Warrick Companies | Merck | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Shire | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
SHIRE CORP | Takeda Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $8,100 |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | pharmaceuticals | environmental violation | 2021 | MA-AG | $600,000 |
Shire LLC | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,850,000 |
SHIRE PLC | Takeda Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $19,070 |
Shire US Inc. | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
Sigma Aldrich Co. | Merck KGaA (EMD) | pharmaceuticals | air pollution violation | 2004 | USAO | $180,000 |
SIGMA ALDRICH MFG LLC | Merck KGaA (EMD) | pharmaceuticals | air pollution violation | 2007 | EPA | $55,000 |
Sigma Aldrich Research Biochemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | export control violation | 2002 | BIS | $1,760,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2011 | FAA | $30,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2013 | FAA | $11,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $23,632 |
SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $10,115 |
SIGMA-ALDRICH INC | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2013 | FAA | $8,000 |
SIGMA-ALDRICH MANUFACTURING | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2014 | IL-ENV | $12,500 |
SIGMA-ALDRICH, INC | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2017 | FAA | $5,000 |
SmithKline Beecham | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
STERILMED, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2006 | OSHA | $11,278 |
SUN PHARMACEUTICAL INDUSTRIES, INC. | Sun Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $9,620 |
Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $17,357,000 |
Synthes Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Synthes USA | Johnson & Johnson | pharmaceuticals | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
Synthes, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2009 | NJ-AG | $236,000 |
Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $150,000,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | AR-AG | $525,780 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | consumer protection violation | 2006 | ID-AG | $198,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | kickbacks and bribery | 2006 | KY-AG | $600,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | kickbacks and bribery | 2006 | WI-AG | $798,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Taro Pharmaceutical USA Inc. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
TARO PHARMACEUTICALS USA, INC. | Sun Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $18,565 |
TEVA PHARMACEUTICAL | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2000 | OSHA | $5,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
TEVA PHARMACEUTICAL USA, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $5,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
TEVA PHARMACEUTICALS INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $15,300 |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | pharmaceuticals | air pollution violation | 2006 | NJ-ENV | $6,200 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | pharmaceuticals | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2003 | MO-AG | $70,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $24,000,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | hazardous waste violation | 2003 | EPA | $61,158 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
TEVA SICOR | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2005 | OSHA | $5,000 |
Therasense, Inc. | Abbott Laboratories | pharmaceuticals | labor relations violation | 2003 | NLRB | $236,827 |
UCB | UCB | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
UCB CHEMICAL CORPORATION | UCB | pharmaceuticals | environmental violation | 2001 | EPA | $6,824 |
UCB Chemicals Corporation | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | private lawsuit-federal | $9,000,000 |
UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
UCB Pharma, Inc. | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
ULTRAGENYX PHARMACEUTICAL | Ultragenyx Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $12,054 |
Ultragenyx Pharmaceutical Inc. | Ultragenyx Pharmaceutical | pharmaceuticals | False Claims Act and related | 2023 | DOJ_CIVIL | $6,000,000 |
United Therapeutics Corporation | United Therapeutics | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $210,000,000 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | Bausch Health | pharmaceuticals | benefit plan administrator violation | 2016 | EBSA | $10,001 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $23,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
Valeant Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | insurance violation | 2018 | CA-INS | $1,875,000 |
VERSUM MATERIALS | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $8,438 |
VERSUM MATERIALS, INC. | Merck KGaA (EMD) | pharmaceuticals | hazardous waste violation | 2020 | EPA | $17,600 |
VISTAKON | Johnson & Johnson | pharmaceuticals | hazardous waste violation | 2005 | FL-DEP | $9,771 |
Warner Chilcott | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $8,000,000 |
Warner Chilcott Holdings | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $9,000,000 |
Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
Warner Chilcott PLC | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | FDA | $125,000,000 |